LANREOTIDE ACETATE
AMNEAL · LANREOTIDE ACETATE
Open FDA's page for this record- Application number
- ANDA218217
- Sponsor name
- AMNEAL
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260918
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- LANREOTIDE ACETATE
- Reference standard
- No
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- LANREOTIDE ACETATE
- Strength
- EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
- Harmonized identifiers (openFDA)
- Application number
- ANDA218217
- Brand name
- LANREOTIDE ACETATE
- Generic name
- LANREOTIDE ACETATE
- Manufacturer name
- Amneal Pharmaceuticals LLC
- Product NDC
- 70121-2517
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- SUBCUTANEOUS
- Substance name
- LANREOTIDE ACETATE
- RxCUI
- 749814
- SPL ID
- 43b3c820-dda0-4514-92cd-3ad85019d105
- SPL set ID
- e240b3b9-7a07-46b5-bacc-04e915d4ebd4
- Package NDC
- 70121-2517-5
- UNII
- IEU56G3J9C
